• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    J&J`s tuberculosis Sirturo lands full US, EU approvals

    FIERCE PHARMA

    NPPA invokes Para 3 of DPCO to direct Macleods to supply anti-TB drug to CMSS

    PHARMABIZ

    Enforcement Report - Week of April 17, 2024

    FDA

    Lupin, Glenmark recall drugs in US market: USFDA

    MONEYCONTROL

    Enforcement Report - Week of February 7, 2024

    FDA

    Fighting tuberculosis: EUROAPI’s rifampicin API meets new requirements for nitrosamine impurity standards

    PRESS RELEASE

    Enforcement Report - Week of June 7, 2023

    FDA

    Enforcement Report - Week of January 25, 2023

    FDA

    Enforcement Report - Week of January 18, 2023

    FDA

    Enforcement Report - Week of October 26, 2022

    FDA

    Enforcement Report - Week of October 5, 2022

    FDA

    Enforcement Report - Week of August 24, 2022

    FDA

    Stopping dementia at the nose with combination of rifampicin and resveratrol

    SCIENCEDAILY

    FDA addresses nitrosamines in TB drugs

    RAPS

    FDA works to mitigate shortages of rifampin and rifapentine after manufacturerE

    FDA

    Health Canada Issues Recalls of Bausch Health, Canada`s Rifampin

    HEALTH CANADA

    Class 4 Medicines Defect Information: Rifadin (rifampicin) 150mg Capsules

    MHRA

    Evotec receives $ 23.8 m grant to join the global fight against tuberculosis

    PRESS RELEASE

    FDA advisory panel recommends approval of TB Alliance`s tuberculosis treatment

    REUTERS

    WHO announces landmark changes in MDR-TB treatment regimens

    ECONOMIC TIMES

    New tuberculosis drug could help eradicate global killer

    PHARMAPHORUM

    Hikma Pharm`s Generic Rifampin approved in US as an antibiotic

    FDA

    ViiV Healthcare Announces PhII Study Results for First Two Drug

    PR NEWSWIRE

    Cholesterol,TB Drugs Recalled in Philippines Due to Failed Dissolution Tests

    NEWS INFERNO

    Drug Regulator Fixes Prices of 30 Formulation Packs

    NDTV

    Antibiotics Made By Emcure Pharmaceuticals Recalled In US

    THE ECONOMIC TIMES

    Heritage Pharmaceuticals, Inc., Ongoing Class II recall of RIFAMPIN for Injection,USP, 600 mg per vial, Rx Only, Manufactured by: Emcure Pharmaceuticals Ltd., Hinjwadi, Pune, India Manufactured for: Heritage Pharmaceuticals Inc., Eatontown, NJ 07724 NDC 23155-340-31 because of Lack of Assurance of Sterility: Firm is recalling two injectable products due to concerns with quality control processes.

    FDA

    HIV New Compound May Treat HIV, Drug-Resistant TB

    THE FINANCIAL EXPRESS

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.